NO173995C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo(2,3b)indolderivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo(2,3b)indolderivaterInfo
- Publication number
- NO173995C NO173995C NO901385A NO901385A NO173995C NO 173995 C NO173995 C NO 173995C NO 901385 A NO901385 A NO 901385A NO 901385 A NO901385 A NO 901385A NO 173995 C NO173995 C NO 173995C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically active
- indole derivatives
- analogous procedures
- active pyrrolo
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 150000005595 pyrrolo[2,3-b]indoles Chemical class 0.000 title 1
- BMBGYEFENKYOKD-UHFFFAOYSA-N (3,4,8b-trimethyl-2,3a-dihydro-1h-pyrrolo[2,3-b]indol-7-yl) hydrogen carbonate Chemical class C1=C(OC(O)=O)C=C2C3(C)CCN(C)C3N(C)C2=C1 BMBGYEFENKYOKD-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/329,171 US4971992A (en) | 1989-03-27 | 1989-03-27 | Carbonate derivatives of eseroline |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO901385D0 NO901385D0 (no) | 1990-03-26 |
| NO901385L NO901385L (no) | 1990-09-28 |
| NO173995B NO173995B (no) | 1993-11-22 |
| NO173995C true NO173995C (no) | 1994-03-02 |
Family
ID=23284183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO901385A NO173995C (no) | 1989-03-27 | 1990-03-26 | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo(2,3b)indolderivater |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4971992A (no) |
| EP (1) | EP0389984B1 (no) |
| JP (1) | JPH0737458B2 (no) |
| KR (1) | KR0163049B1 (no) |
| AT (1) | ATE124044T1 (no) |
| AU (1) | AU621208B2 (no) |
| CA (1) | CA2013087C (no) |
| DE (1) | DE69020205T2 (no) |
| DK (1) | DK0389984T3 (no) |
| ES (1) | ES2075081T3 (no) |
| FI (1) | FI92932C (no) |
| HU (1) | HU204053B (no) |
| IE (1) | IE67449B1 (no) |
| IL (1) | IL93895A (no) |
| NO (1) | NO173995C (no) |
| NZ (1) | NZ233065A (no) |
| PT (1) | PT93535B (no) |
| ZA (1) | ZA902307B (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
| US4914102A (en) * | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
| US5077289A (en) * | 1989-11-30 | 1991-12-31 | Hoechst Roussel Pharmaceuticals Inc. | Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine |
| US4983616A (en) * | 1990-02-01 | 1991-01-08 | Hoechst-Roussel Pharmaceuticals Inc. | Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds |
| US5216017A (en) * | 1990-05-11 | 1993-06-01 | Hoechst-Roussel Pharmaceuticals Incorporated | Pyrrolo[2,3-b]indole-ketones and analogs |
| AU634654B2 (en) * | 1990-05-11 | 1993-02-25 | Hoechst-Roussel Pharmaceuticals Incorporated | Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments |
| AU634380B2 (en) * | 1990-05-17 | 1993-02-18 | Hoechst-Roussel Pharmaceuticals Incorporated | Alpha-oxopyrrolo(2,3-b)indole acetic acids, esters, amides and related analogs, a process for their preparation and their use as medicaments |
| DE4139763A1 (de) * | 1991-12-03 | 1993-06-09 | Kali-Chemie Pharma Gmbh, 3000 Hannover, De | Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel |
| US5409948A (en) * | 1992-11-23 | 1995-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating cognitive disorders with phenserine |
| AT404907B (de) * | 1993-07-13 | 1999-03-25 | Andritz Patentverwaltung | Verfahren und anlage zum herstellen von edelstahlband |
| US5665880A (en) * | 1996-10-31 | 1997-09-09 | Hoechst Marion Roussel, Inc. | Method of preparation of physostigmine carbamate derivatives from eseretholes |
| US5677457A (en) * | 1996-12-19 | 1997-10-14 | Hoechst Marion Roussel, Inc. | Method of preparation of physostigmine carbamate derivatives from eseroline ethers |
| US20050182044A1 (en) * | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
| CA2508585A1 (en) * | 2004-06-01 | 2005-12-01 | Axonyx, Inc. | Transdermal delivery system for treatment of cognitive disorders |
| WO2005123068A2 (en) * | 2004-06-08 | 2005-12-29 | Axonyx, Inc. | Methods of dealying alzheimer’s disease progression using a beta-amyloid precursor protein inhibitor and a hmg coa reductase inhibitor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1109003B (it) * | 1977-09-20 | 1985-12-16 | Univ Firenze | Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo |
| US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
| US4914102A (en) * | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
| US5077289A (en) * | 1989-11-30 | 1991-12-31 | Hoechst Roussel Pharmaceuticals Inc. | Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine |
-
1989
- 1989-03-27 US US07/329,171 patent/US4971992A/en not_active Expired - Lifetime
-
1990
- 1990-03-22 PT PT93535A patent/PT93535B/pt not_active IP Right Cessation
- 1990-03-23 ES ES90105562T patent/ES2075081T3/es not_active Expired - Lifetime
- 1990-03-23 FI FI901470A patent/FI92932C/fi not_active IP Right Cessation
- 1990-03-23 NZ NZ233065A patent/NZ233065A/en unknown
- 1990-03-23 EP EP90105562A patent/EP0389984B1/en not_active Expired - Lifetime
- 1990-03-23 DK DK90105562.4T patent/DK0389984T3/da active
- 1990-03-23 DE DE69020205T patent/DE69020205T2/de not_active Expired - Lifetime
- 1990-03-23 AT AT90105562T patent/ATE124044T1/de not_active IP Right Cessation
- 1990-03-26 IL IL9389590A patent/IL93895A/en not_active IP Right Cessation
- 1990-03-26 JP JP2073603A patent/JPH0737458B2/ja not_active Expired - Lifetime
- 1990-03-26 HU HU901832A patent/HU204053B/hu unknown
- 1990-03-26 IE IE109790A patent/IE67449B1/en not_active IP Right Cessation
- 1990-03-26 NO NO901385A patent/NO173995C/no unknown
- 1990-03-26 KR KR1019900004027A patent/KR0163049B1/ko not_active Expired - Fee Related
- 1990-03-26 ZA ZA902307A patent/ZA902307B/xx unknown
- 1990-03-26 CA CA002013087A patent/CA2013087C/en not_active Expired - Lifetime
- 1990-03-27 AU AU52202/90A patent/AU621208B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| NZ233065A (en) | 1992-04-28 |
| NO901385L (no) | 1990-09-28 |
| HUT54159A (en) | 1991-01-28 |
| KR0163049B1 (ko) | 1998-12-01 |
| HU204053B (en) | 1991-11-28 |
| US4971992A (en) | 1990-11-20 |
| ES2075081T3 (es) | 1995-10-01 |
| ATE124044T1 (de) | 1995-07-15 |
| DK0389984T3 (da) | 1995-10-30 |
| EP0389984B1 (en) | 1995-06-21 |
| ZA902307B (en) | 1990-12-28 |
| NO901385D0 (no) | 1990-03-26 |
| AU621208B2 (en) | 1992-03-05 |
| IE67449B1 (en) | 1996-04-03 |
| IL93895A0 (en) | 1990-12-23 |
| EP0389984A1 (en) | 1990-10-03 |
| AU5220290A (en) | 1990-11-08 |
| FI92932C (fi) | 1995-01-25 |
| JPH0737458B2 (ja) | 1995-04-26 |
| HU901832D0 (en) | 1990-08-28 |
| PT93535B (pt) | 1996-03-29 |
| IE901097L (en) | 1990-09-27 |
| IL93895A (en) | 1995-07-31 |
| JPH02289572A (ja) | 1990-11-29 |
| CA2013087A1 (en) | 1990-09-27 |
| FI901470A0 (fi) | 1990-03-23 |
| CA2013087C (en) | 1999-12-28 |
| FI92932B (fi) | 1994-10-14 |
| PT93535A (pt) | 1990-11-07 |
| DE69020205D1 (de) | 1995-07-27 |
| KR900014388A (ko) | 1990-10-23 |
| DE69020205T2 (de) | 1995-12-07 |
| NO173995B (no) | 1993-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO173995C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo(2,3b)indolderivater | |
| CA2029265A1 (en) | 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments | |
| NO175310C (no) | Analogifremgangsmåte til fremstilling av terapeutisk aktive pyrrolo(2,3-b)indolderivater | |
| AU636351B2 (en) | N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments | |
| DE3873786D1 (de) | Substituierte 1,3,4,9-tetrahydropyrano(3,4-b)indol-1-essigsaeuren. |